Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines-Reference-Cited by-同舟云学术

Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH–mefenamato drug conjugates against human cancer cell lines

Published:2020 Issue:1 Volume:10 Page:166-178
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Khan Huzaifa Yasir¹²³⁴,Tabassum Sartaj¹²³⁴^ORCID,Arjmand Farukh¹²³⁴^ORCID

Affiliation:

1. Department of Chemistry

2. Aligarh Muslim University

3. Aligarh 202002

4. India

Abstract

New RNA targeted ionic NSAID drug conjugates were evaluated for their antiproliferative activity against human cancer cell lines.

Funder

Department of Science and Technology, Ministry of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/C9RA07464C

Reference62 articles.

1. Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes

2. Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues

3. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

4. Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level

5. Non-Steroidal Anti-Inflammatory Drugs

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of the Tungsten(VI) complex of hydroxamic acid's RNA binding affinity, histone deacetylase inhibitory activity, and antioxidant activity;Journal of Molecular Structure;2024-09

2. Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future;Medicinal Research Reviews;2024-08-22

3. A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs;Drug Discovery Today;2024-07

4. Repurposing the antihistamine drug bilastine as an anti-cancer metallic drug entity: synthesis and single-crystal X-ray structure analysis of metal-based bilastine and phen [Co(ii), Cu(ii) and Zn(ii)] tailored anticancer chemotherapeutic agents against resistant cancer cells;Dalton Transactions;2024

5. Classification of Metal-Based Anticancer Chemotherapeutic Agents;Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates;2024